4553.T लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:45):

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan...

Stats
आज की मात्रा	94 800.00
औसत मात्रा	167 551
बाजार मूल्य	136.48B
EPS	¥0 ( 2024-02-12 )
अगली कमाई की तारीख	( ¥38.66 ) 2024-05-12
Last Dividend	¥30.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	11.63
ATR14	¥1.288 (0.05%)

मात्रा सहसंबंध

लंबा: -0.07 (neutral)

छोटा: -0.30 (neutral)

Signal:(59.213) Neutral

Towa Pharmaceutical Co., सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Towa Pharmaceutical Co., सहसंबंध - मुद्रा/वस्त्र

-0.03
( neutral )

0.18
( neutral )

-0.04
( neutral )

-0.37
( neutral )

0.32
( neutral )

-0.02
( neutral )

Towa Pharmaceutical Co., वित्तीय

Annual	2022
राजस्व:	¥208.86B
सकल लाभ:	¥72.71B (34.81 %)
EPS:	¥44.72

FY	2022
राजस्व:	¥208.86B
सकल लाभ:	¥72.71B (34.81 %)
EPS:	¥44.72

FY	2022
राजस्व:	¥165.62B
सकल लाभ:	¥70.19B (42.38 %)
EPS:	¥323.36

FY	2021
राजस्व:	¥154.90B
सकल लाभ:	¥65.45B (42.25 %)
EPS:	¥283.62

Financial Reports:

No articles found.

Towa Pharmaceutical Co., Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥30.00 (N/A)	¥0 (N/A)	¥30.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Towa Pharmaceutical Co., Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.24 - good (92.41%) | Divividend Growth Potential Score: 4.05 - Stable (19.05%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥1.667	2005-03-28
Last Dividend	¥30.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	38	--
Total Paid Out	¥541.50	--
Avg. Dividend % Per Year	0.00%	--
Score	3.37	--
Div. Sustainability Score	9.24
Div.Growth Potential Score	4.05
Div. Directional Score	6.64	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.27 %

Dividend Stability

0.10 Bad

Dividend Score

3.37

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7872.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
7013.T	No Dividend Player	2023-09-28	Annually	0.00%
6362.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
5233.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4324.T	Ex Dividend Junior	2023-12-28	Semi-Annually	0.00%
3488.T	Ex Dividend Junior	2023-08-30	Semi-Annually	0.00%
2726.T	Ex Dividend Junior	2024-02-28	Annually	0.00%
9619.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8157.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7516.T	Ex Dividend Junior	2024-02-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0496	1.500	9.01	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0283	1.200	9.06	10.00	[0 - 0.3]
returnOnEquityTTM	0.0814	1.500	-0.207	-0.310	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.77	0.800	1.148	0.919	[1 - 3]
quickRatioTTM	1.173	0.800	7.81	6.25	[0.8 - 2.5]
cashRatioTTM	0.399	1.500	8.89	10.00	[0.2 - 2]
debtRatioTTM	0.473	-1.500	2.12	-3.17	[0 - 0.6]
interestCoverageTTM	16.44	1.000	5.02	5.02	[3 - 30]
operatingCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	1.318	-1.500	4.73	-7.09	[0 - 2.5]
grossProfitMarginTTM	0.347	1.000	7.56	7.56	[0.2 - 0.8]
operatingProfitMarginTTM	0.0564	1.000	-0.871	-0.871	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.206	1.000	9.97	9.97	[0.2 - 2]
assetTurnoverTTM	0.571	0.800	9.53	7.62	[0.5 - 2]
Total Score				9.24

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	11.63	1.000	8.93	0	[1 - 100]
returnOnEquityTTM	0.0814	2.50	-0.133	-0.310	[0.1 - 1.5]
freeCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.16	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	821.31	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.135	1.500	-4.23	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.171	1.000	8.23	0	[0.1 - 0.5]
Total Score				4.05

Towa Pharmaceutical Co.,

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of diabetes, digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It had a portfolio of approximately 700 drug products. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Osaka, Japan.